Wojcik EM - Search Results

1

Risk assessment for occult malignancy in the prostate before radical cystectomy.

Kefer JC, Voelzke BB, Flanigan RC, Wojcik EM, Waters WB, Campbell SC. Kefer JC, et al. Among authors: wojcik em. Urology. 2005 Dec;66(6):1251-5. doi: 10.1016/j.urology.2005.07.006. Urology. 2005. PMID: 16360452

2

Carcinosarcoma of the prostate.

Koleski FC, Turk TM, Wojcik EM, Albala DM. Koleski FC, et al. Among authors: wojcik em. World J Urol. 1999 Oct;17(5):316-8. doi: 10.1007/s003450050153. World J Urol. 1999. PMID: 10552151

3

Comparative analysis of DNA flow cytometry and cytology of bladder washings: review of discordant cases.

Bakhos R, Shankey TV, Flanigan RC, Fisher S, Wojcik EM. Bakhos R, et al. Among authors: wojcik em. Diagn Cytopathol. 2000 Feb;22(2):65-9. doi: 10.1002/(sici)1097-0339(200002)22:2<65::aid-dc2>3.0.co;2-k. Diagn Cytopathol. 2000. PMID: 10649514

4

The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: implications for treatment selection.

Gao X, Mohideen N, Flanigan RC, Waters WB, Wojcik EM, Leman CR. Gao X, et al. Among authors: wojcik em. J Urol. 2000 Dec;164(6):1982-6. J Urol. 2000. PMID: 11061896

5

Prostatic levels of fatty acids and the histopathology of localized prostate cancer.

Freeman VL, Meydani M, Yong S, Pyle J, Flanigan RC, Waters WB, Wojcik EM. Freeman VL, et al. Among authors: wojcik em. J Urol. 2000 Dec;164(6):2168-72. J Urol. 2000. PMID: 11061949

6

T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer.

Mercader M, Bodner BK, Moser MT, Kwon PS, Park ES, Manecke RG, Ellis TM, Wojcik EM, Yang D, Flanigan RC, Waters WB, Kast WM, Kwon ED. Mercader M, et al. Among authors: wojcik em. Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14565-70. doi: 10.1073/pnas.251140998. Proc Natl Acad Sci U S A. 2001. PMID: 11734652 Free PMC article. Clinical Trial.

7

Cytologic features of recurrent lymphoma involving the urinary bladder.

Quinn AM, Flanigan R, Sienko A, Wojcik EM. Quinn AM, et al. Among authors: wojcik em. Diagn Cytopathol. 2004 Sep;31(3):185-8. doi: 10.1002/dc.20099. Diagn Cytopathol. 2004. PMID: 15349991

8

Morphometric sum optical density as a surrogate marker for ploidy status in prostate cancer: an analysis in 180 biopsies using logistic regression and binary recursive partitioning.

Venkataraman G, Ananthanarayanan V, Paner GP, He R, Masoom S, Sinacore J, Flanigan RC, Wojcik EM. Venkataraman G, et al. Among authors: wojcik em. Virchows Arch. 2006 Sep;449(3):302-7. doi: 10.1007/s00428-006-0237-y. Epub 2006 Aug 3. Virchows Arch. 2006. PMID: 16896895

9

Utility of prostate biopsy morphometric sum optical density for identifying extraprostatic extension on subsequent prostatectomy.

Bargaje A, Venkataraman G, Flanigan R, Wojcik EM, Ananthanarayanan V. Bargaje A, et al. Among authors: wojcik em. Anal Quant Cytol Histol. 2006 Dec;28(6):343-5. Anal Quant Cytol Histol. 2006. PMID: 17220151 No abstract available.

10

Identification of patients with low-risk for aneuploidy: comparative discriminatory models using linear and machine-learning classifiers in prostate cancer.

Venkataraman G, Heinze G, Holmes EW, Ananthanarayanan V, Bostwick DG, Paner GP, Bradford-De La garza CM, Brown HG, Flanigan RC, Wojcik EM. Venkataraman G, et al. Among authors: wojcik em. Prostate. 2007 Oct 1;67(14):1524-36. doi: 10.1002/pros.20629. Prostate. 2007. PMID: 17683063

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters